Therefore, before constructing the TAAs-derived peptides expressing rVACV, we evaluated the expression of the SPARC protein and MHC class I molecules H2-Kd and H2-Ld in mammary cancer cell lines 4T1 and N2C by western blot analysis and flow cytometry. Here, SPARC is linked to breast cancer.